Skip to main content
Equibles

Benjamin Looker

General Counsel

Esperion Therapeutics, Inc.

Esperion Therapeutics, Inc.

Equibles does not estimate personal net worth.

About Benjamin Looker

Benjamin Looker is recorded as General Counsel at Esperion Therapeutics, Inc.. The newest filing on record that lists Benjamin Looker as General Counsel at Esperion Therapeutics, Inc. is dated April 17, 2025. The proxy statement of Esperion Therapeutics, Inc. reports total compensation of $1,130,827 for Benjamin Looker in fiscal 2024, including a base salary of $471,000. Disclosed compensation is on record for 2 fiscal years. Esperion Therapeutics, Inc. is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector.

Affiliation history

  • Esperion Therapeutics, Inc.

    General Counsel

    Proxy statement

    Current

    Start not stated–present

    Last confirmed April 17, 2025

  • Esperion Therapeutics, Inc.

    Proxy statement

    Current

    Start not stated–present

    Last confirmed April 16, 2026

Company network

Esperion Therapeutics, Inc.

Current role

Drug Manufacturers - Specialty & Generic · Healthcare

General Counsel

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2024 Esperion Therapeutics, Inc. $471,000 $1,130,827
2022 Esperion Therapeutics, Inc. $375,000 $1,293,772

Recent activity

No call appearances or filed executive changes recorded yet.